The bench, the director, and the person who closes the books.

Most of what I did on the old system was tell the computer things it already knew. Every presumptive positive meant pulling the medication history in one window, the ion ratios in another, and re-keying half of it into a review form. Now the confirmation worklist comes up pre-populated and flags only the parameters that are out of spec. I look at the ones that need a person and release the rest. That is the job I was trained for.

We were running an LIS and a billing platform from two vendors and one person whose entire job was reconciling them. Month-end close took four days. On Lab A SaaS the claim is built off the order record, so there is nothing to reconcile — a denial opens attached to the accession that caused it. That role got its time back, and we stopped finding missed revenue sixty days late.

Changing an LIS is the thing every lab director puts off, because a bad week of accessions is a week you do not get back. Two things moved us. We asked four vendors about our analyzer list, and Lab A SaaS was the only one that came back with what they had already built instead of a quote for development. Then the cutover itself was quiet — we ran parallel for two weeks, went live on a Monday, and our client practices never noticed.

Multi-site was the requirement that eliminated most of the vendors we looked at. Plenty of platforms will tell you they support multiple locations, and what they mean is they will spin up a second instance. Lab A SaaS is multi-tenant in the data model, so a second site is a configuration rather than a project.